BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/25/2023 2:17:08 PM | Browse: 96 | Download: 213
 |
Received |
|
2023-01-05 15:38 |
|
Peer-Review Started |
|
2023-01-05 15:40 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-01-19 18:32 |
|
Revised |
|
2023-01-23 17:08 |
|
Second Decision |
|
2023-05-15 03:38 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-05-15 09:26 |
|
Articles in Press |
|
2023-05-15 09:26 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-06-13 08:37 |
|
Publish the Manuscript Online |
|
2023-06-25 14:17 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Liver injury from direct oral anticoagulants
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Deven Juneja, Prashant Nasa and Ravi Jain |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Prashant Nasa, MD, Chief Doctor, Critical Care Medicine, NMC Specialty Hospital, Amman Street, Al Nahda 2, Dubai 7832, United Arab Emirates. dr.prashantnasa@gmail.com |
| Key Words |
Anticoagulants; Direct-acting oral anticoagulants; Drug induced liver injury; Drug reactions; Hepatotoxicity; Novel oral anticoagulants |
| Core Tip |
Drug-induced liver injury (DILI) can be ascribed to practically any prescribed drug. The side effect profile of relatively newer direct-acting oral anticoagulants (DOACs) is yet to be completely determined. Even though the data from earlier clinical trials suggested no significant liver toxicity, several case reports and series describing DOAC-induced DILI have been recently published. Most of these cases have been reported in elderly patients, not on concomitant hepatotoxic drugs. However, these patients may have good clinical outcomes, with complete recovery of liver function, if an early diagnosis is made and the offending agent is stopped. |
| Publish Date |
2023-06-25 14:17 |
| Citation |
Juneja D, Nasa P, Jain R. Liver injury from direct oral anticoagulants. World J Hepatol 2023; 15(6): 841-849 |
| URL |
https://www.wjgnet.com/1948-5182/full/v15/i6/841.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v15.i6.841 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
